Erasmus School of Health Policy & Management
Associate professor | Health Systems and Insurance (HSI)
- franzen@eshpm.eur.nl
More information
Work
- N. Franzen, J. Vancoppenolle, V. P. Retèl, S. Vogler & W. H. van Harten (2026) - A comparative analysis of managed entry agreements in Europe: trends, reporting practices, and financial outcomes - European Journal of Health Economics - doi: 10.1007/s10198-026-01942-3 - [link]
- Jasper Ubels, Julie M. Vancoppenolle, Josephine Tetteh, Wim H. van Harten, Valesca P. Retèl, Michael Schlander & Nora Franzen (2026) - Toward a validated European instrument to measure the socioeconomic impact of cancer - International Journal of Cancer, 158 (12), 3288-3299 - doi: 10.1002/ijc.70364 - [link]
- Julie Vancoppenolle, Nora Franzen, Cristina Andrianò, Morten Baltzer Houlind, Zora Ćetković, Aniek Dane, Albane Degrassat-Théas, Anne M.P. Eldering-Heldens, Martin J. Hug, Holger Knoth, Vito Ladisa, Péter Vajda, Ulrich Warnke, Valesca Retèl & Wim H. van Harten (2026) - Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region - Frontiers in Pharmacology, 17 - doi: 10.3389/fphar.2026.1736741 - [link]
- Zainab Al-Khayat, Nora Franzen, Valesca P. Retèl & Wim H. Van Harten (2025) - Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews - BMJ open, 15 (12) - doi: 10.1136/bmjopen-2025-100304 - [link]
- Julie M. Vancoppenolle, Silvie H.M. Janssen, Nora Franzen, Winette T.A. van der Graaf, Valesca Retel, Olga Husson & Wim van Harten (2025) - Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective - International Journal of Cancer, 157 (7), 1433-1445 - doi: 10.1002/ijc.35488 - [link]
- J. Vancoppenolle, N. Franzen, L. Azarang, T. Juslin, M. Krini, T. Lubbers, J. Mattson, D. Mayeur, R. Menezes, J. Schmitt, F. Scotte, O. Seoane López, T. Skaali, J. Ubels, M. Schlander, V. Retel, W. H. van Harten & (2025) - Financial toxicity and socioeconomic impact of cancer in Europe - ESMO Open, 10 (6) - doi: 10.1016/j.esmoop.2025.105293 - [link]
- Jinjing Fu, Nora Franzen, Eline Aas, J. C. Koen van der Mijn, Pim J. van Leeuwen & Valesca P. Retel (2025) - Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer - Value in Health, 28 (5), 720-729 - doi: 10.1016/j.jval.2025.02.004 - [link]
Medical Innovation and Intellectual Prop
- Level
- master
- Year Level
- master
- Year
- 2026
- Course Code
- BM04MBI
Competition in Health Care Markets
- Year Level
- master, master, master
- Year
- 2026
- Course Code
- GW4573M
